Your food and beverage industry news from the United States

Provided by AGP

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
J&F Announces Expiration and Final Tender Results of Exchange Offer for Eldorado’s 8.500% Senior Notes Due 2032
3 hours ago

J&F Announces Expiration and Final Tender Results of Exchange Offer for Eldorado’s 8.500% Senior Notes Due 2032

GlobeNewswire, Inc.

‘Do the Small Things Well’: AMC HQ’s Employee of the Quarter recognized for driving Army food modernization
9 hours ago

‘Do the Small Things Well’: AMC HQ’s Employee of the Quarter recognized for driving Army food modernization

DVIDS - Georgia

A Debt of Honor: US Colonel Pays Tribute to 11 African American Soldiers Massacred During World War II
13 hours ago

A Debt of Honor: US Colonel Pays Tribute to 11 African American Soldiers Massacred During World War II

DVIDS - Georgia

World’s First 7th-Generation Fully Automated Robot Café to Debut At 2026 NRA Show in Chicago
13 hours ago

World’s First 7th-Generation Fully Automated Robot Café to Debut At 2026 NRA Show in Chicago

GlobeNewswire, Inc.

DAVE & BUSTER’S KING OF PRUSSIA LAUNCHES FLAG HUNT FOR VIP ACCESS & PRIZES AHEAD OF GRAND OPENING
14 hours ago

DAVE & BUSTER’S KING OF PRUSSIA LAUNCHES FLAG HUNT FOR VIP ACCESS & PRIZES AHEAD OF GRAND OPENING

EIN Presswire

The Boston Beer Company Lights Up Ready-To-Drink Market with All-New 15% Alc. LYTT® Electric Coolers™
14 hours ago

The Boston Beer Company Lights Up Ready-To-Drink Market with All-New 15% Alc. LYTT® Electric Coolers™

GlobeNewswire, Inc.

AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases
15 hours ago

AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases

GlobeNewswire, Inc.

Sironax’s SARM1 Inhibitor SIR2501 Granted FDA Fast Track Designation in Chemotherapy-induced Peripheral Neuropathy (CIPN)
15 hours ago

Sironax’s SARM1 Inhibitor SIR2501 Granted FDA Fast Track Designation in Chemotherapy-induced Peripheral Neuropathy (CIPN)

GlobeNewswire, Inc.

MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results
May. 10, 2026

MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results

GlobeNewswire, Inc.

Bringing your pet to Okinawa: What to expect and who’s here to help
May. 10, 2026

Bringing your pet to Okinawa: What to expect and who’s here to help

DVIDS - Georgia

News Release – PFAS Detected in Haleakalā national Park Water System
8 hours ago

News Release – PFAS Detected in Haleakalā national Park Water System

Governor of State of Hawaii

34TH ANNUAL WILDFLOWER! ARTS & MUSIC FESTIVAL RETURNS MAY 15-17 WITH 100+ LIVE PERFORMANCES ACROSS SIX STAGES
4 hours ago

34TH ANNUAL WILDFLOWER! ARTS & MUSIC FESTIVAL RETURNS MAY 15-17 WITH 100+ LIVE PERFORMANCES ACROSS SIX STAGES

EIN Presswire

Creating Jobs in Philadelphia: Governor Shapiro Secures $3.8 Million Investment from Bonduelle Americas to Open its New U.S. Growth Hub in Pennsylvania, Creating Over 100 Jobs
May. 8, 2026

Creating Jobs in Philadelphia: Governor Shapiro Secures $3.8 Million Investment from Bonduelle Americas to Open its New U.S. Growth Hub in Pennsylvania, Creating Over 100 Jobs

Pennsylvania Department of Community & Economic Development

Creating Jobs in Philadelphia: Governor Shapiro Secures $3.8 Million Investment from Bonduelle Americas to Open its New U.S. Growth Hub in Pennsylvania, Creating Over 100 Jobs
May. 8, 2026

Creating Jobs in Philadelphia: Governor Shapiro Secures $3.8 Million Investment from Bonduelle Americas to Open its New U.S. Growth Hub in Pennsylvania, Creating Over 100 Jobs

Pennsylvania Department of Community & Economic Development

Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
May. 8, 2026

Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)

GlobeNewswire, Inc.

argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
May. 8, 2026

argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG

GlobeNewswire, Inc.

Cassava Roots Launches U.S. Franchise Model in 2026
May. 8, 2026

Cassava Roots Launches U.S. Franchise Model in 2026

GlobeNewswire, Inc.

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
May. 7, 2026

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology

GlobeNewswire, Inc.

Officials From Canada, Mexico and United States Gather in Regina for Tri National Conference
May. 6, 2026

Officials From Canada, Mexico and United States Gather in Regina for Tri National Conference

Government of Saskatchewan

TOMI Environmental Solutions (Nasdaq: TOMZ) Clarifies Previously Announced $120M Preferred Stock LOI to Merge with Carbonium Core, Entering U.S. Nuclear-Grade Graphite Market for Advanced Reactors Within a $13–15B Global Graphite Industry
May. 7, 2026

TOMI Environmental Solutions (Nasdaq: TOMZ) Clarifies Previously Announced $120M Preferred Stock LOI to Merge with Carbonium Core, Entering U.S. Nuclear-Grade Graphite Market for Advanced Reactors Within a $13–15B Global Graphite Industry

GlobeNewswire, Inc.

Sign up for:

American Food & Beverage Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share us

on your social networks: